About World ADC San Diego
Your Definitive Antibody Drug Conjugate Networking Experience
In the last 12 months, we’ve seen the approval of Besponsa, re-approval of Mylotarg, innovations in ADC linker, payload and antibody technologies and there are now over 79 ADCs in clinical development. Yet, as we all know maximizing the clinical therapeutic index of ADCs is a challenge we’re continuing the grapple with.
As such, there is a lot to be shared and digested at this year’s World ADC San Diego. Now in its 9th year, World ADC San Diego is the industry’s most comprehensive antibody drug conjugate conference. Designed with AbbVie Stemcentrx, Seattle Genetics and ImmunoGen this leading forum shares the latest data, insight and lessons learned enabling you to maximize the clinical therapeutic window of your ADC candidate.
Across 4 days, over 650 ADC stakeholders from 220 organizations will converge at World ADC to providing you with an unrivalled networking experience.
Join the ADC community to catch up with friends, meet new peers and further progress partnerships.